Friday, 30 October 2026European Markets

KEYWARE TECH. Stock Went Down By Over 17% So Far On Wednesday

Loading stream...

(VIANEWS) - Shares of KEYWARE TECH. (BEL 20: KEYW.BR) dropped by a staggering 17.48% to €0.85 at 11:21 EST on Wednesday, after five sequential sessions in a row of losses. BEL 20 is dropping 0.33% to €3,804.66, after three sequential sessions in a row of gains. This seems, as yet, a somewhat bearish trend trading session today.

KEYWARE TECH.'s last close was €0.98, 14.78% under its 52-week high of €1.15.

About KEYWARE TECH.

Keyware Technologies NV, an independent fintech company, provides electronic payment solutions in Belgium. It offers payment transaction software for banks and financial institutions, tokenization software, instalment payment solutions, and ordering and payment app software; and payment processing and management services, as well as engages in the rental and sale of payment terminals. The company was incorporated in 1996 and is headquartered in Zaventem, Belgium.

Earnings Per Share

As for profitability, KEYWARE TECH. has a trailing twelve months EPS of €0.05.

PE Ratio

KEYWARE TECH. has a trailing twelve months price to earnings ratio of 17. Meaning, the purchaser of the share is investing €17 for every euro of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 2.37%.

Moving Average

KEYWARE TECH.'s value is way below its 50-day moving average of €1.01 and way under its 200-day moving average of €1.02.

Revenue Growth

Year-on-year quarterly revenue growth grew by 27.9%, now sitting on 17.69M for the twelve trailing months.

Volume

Today's last reported volume for KEYWARE TECH. is 3 which is 99.84% below its average volume of 1899.

Yearly Top and Bottom Value

KEYWARE TECH.'s stock is valued at €0.85 at 11:21 EST, way under its 52-week high of €1.15 and higher than its 52-week low of €0.81.

More news about KEYWARE TECH. (KEYW.BR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com